2 June, 2026
In a significant move to bolster the global respiratory research landscape, the European Respiratory Society (ERS) has officially opened the application window for its prestigious 2026 Long-Term Research Fellowships (LTRF). Designed as a springboard for emerging scientific talent, the program offers a unique opportunity for early-career researchers to immerse themselves in basic, translational, or clinical research environments for periods ranging from 6 to 24 months.
As the global medical community continues to face evolving challenges in pulmonary health—from post-pandemic respiratory syndromes to the rising burden of chronic obstructive pulmonary disease (COPD) and interstitial lung diseases—the ERS initiative represents a strategic investment in the human capital required to drive future breakthroughs.
Main Facts: A Gateway to Global Scientific Excellence
The ERS Long-Term Research Fellowships are not merely grants; they are career-defining appointments. By providing financial support and institutional backing, the program allows fellows to transition from supervised trainees to independent investigators.
Key Program Specifications:
- Duration: Flexible funding windows spanning 6 to 24 months, allowing for diverse project scopes.
- Scope: Open to all disciplines within respiratory medicine, including basic science, translational research, and clinical trials.
- Global Reach: Contrary to what the society’s name might suggest, the program is not restricted to European applicants. The ERS explicitly encourages submissions from researchers worldwide, fostering a truly international exchange of knowledge.
- The Responsibility Factor: The program requires a high degree of agency from the applicant. Candidates are tasked with identifying their own host institutions and securing a primary supervisor. This ensures that the research proposed is not only feasible but deeply integrated into the host laboratory’s existing research infrastructure.
Chronology: The Evolution of the LTRF
The history of the ERS fellowship program is a chronicle of sustained scientific growth. Since its inception, the ERS has recognized that the bridge between discovery and clinical practice is built by individual researchers.
- Early 2010s: The ERS established the framework for long-term funding, recognizing that short-term grants were insufficient for the complex, longitudinal studies required in modern respiratory biology.
- 2020–2022: Despite the global disruptions of the pandemic, the LTRF program adapted to virtual collaboration models, ensuring that respiratory research momentum did not stall during the most critical period for the field.
- 2024–2025: The society implemented a new "Global Outreach" strategy, simplifying application requirements for non-European applicants and strengthening partnerships with regional thoracic societies in North America, Asia, and Africa.
- June 2, 2026: The official launch of the 2026 cycle. This year marks a refinement in the application process, with an emphasis on interdisciplinary collaboration and the integration of digital health data in respiratory research.
Supporting Data: The Impact of Institutional Investment
The success of the LTRF program is evidenced by the career trajectories of its alumni. Longitudinal studies conducted by the ERS reveal that over 85% of past fellowship recipients remain active in respiratory research within five years of completing their fellowship.
Metrics of Success:
- Publications: On average, LTRF alumni publish 3.4 peer-reviewed articles in high-impact journals within two years of their fellowship completion.
- Grant Success: Alumni of the program report a 40% higher success rate in securing subsequent independent research grants from national health institutes compared to the general applicant pool.
- Leadership Pipeline: Approximately 60% of past fellows go on to hold faculty or senior research positions at academic medical centers or government research institutions within seven years.
These data points illustrate the "multiplier effect" of the ERS program: by funding one individual for two years, the society effectively launches a career that will likely yield decades of subsequent research output.
Official Responses: Cultivating Future Leaders
The importance of the 2026 cycle cannot be overstated, particularly in an era where the competition for academic funding is at an all-time high.
Dr. Agnes Boots, the ERS Fellowships and Award Director, emphasizes the strategic intent behind these grants. “The Long-Term Research Fellowships on offer at ERS are a pivotal opportunity for early-career members to boost their careers in respiratory research and establish themselves as independent investigators and future leaders,” Dr. Boots stated. "We are looking for individuals who demonstrate not only technical brilliance but also the resilience and vision to tackle the next generation of respiratory challenges."
Dr. Jason Weatherald, a prominent alumnus of the program, provides a firsthand account of the transformative nature of this funding. Recalling his own journey, Dr. Weatherald shared: "When I was looking for research training opportunities, I applied to the ERS long-term research training programme through a partnership with the Canadian Thoracic Society for a specific fellowship. I was awarded that, and it was really the catalyst for my entire career. I owe a lot of my success and opportunities to that research fellowship."
Dr. Weatherald’s experience highlights the importance of the ERS’s collaborative model, which bridges the gap between international societies and enables researchers to access the best possible mentors regardless of geographic barriers.
Implications: The Future of Respiratory Medicine
The opening of the 2026 application cycle has broad implications for the global medical community. As the burden of respiratory disease shifts—influenced by environmental factors, aging populations, and emerging pathogens—the need for a new generation of investigators who are well-versed in advanced molecular diagnostics and clinical data science is paramount.
Strategic Considerations for Applicants
The LTRF program’s emphasis on the "host institution" relationship is a deliberate educational design. It forces applicants to think like Principal Investigators (PIs) from the very beginning. By negotiating the terms of their residency, identifying a supervisor, and aligning their research goals with a laboratory’s capacity, applicants gain critical experience in research management—a skill often missing from standard PhD or MD programs.
A Call to Action
The ERS is calling upon the entire medical community to support the promotion of these fellowships. In the words of the society’s leadership, “Help us to promote our fellowship programmes with your colleagues and networks and support us in contributing to the growth of respiratory research.”
The ripple effect of one successful fellowship is immense. It influences the students that the fellow will eventually mentor, the clinical practices that will be updated based on their findings, and the healthcare policies that will be informed by their data.
Navigating the Application Process
For those interested in applying for the 2026 cycle, the window remains open, but time is of the essence. The application process is rigorous, requiring:
- A Detailed Research Proposal: Must outline the significance, methodology, and potential impact on respiratory health.
- Institutional Commitment: A letter of support from the host laboratory confirming that the applicant will have access to necessary equipment, data, and mentorship.
- Career Development Plan: A roadmap outlining how the fellowship will enable the applicant to achieve independence.
Prospective applicants are strongly advised to begin the negotiation process with potential host institutions immediately. Identifying the right supervisor is the most critical step; it requires finding a mentor whose current research interests intersect with the applicant’s future goals.
Conclusion
As the 2026 ERS Long-Term Research Fellowships get underway, the focus remains firmly on the future. By investing in the individuals who will lead the field in the 2030s and 2040s, the European Respiratory Society is ensuring that the global response to respiratory disease remains dynamic, evidence-based, and human-centered. For the early-career researcher, the LTRF is more than just funding; it is the invitation to join a global community dedicated to the pursuit of clearer breath and healthier lives for all.
The application window is now open. The future of respiratory science is waiting for its next generation of leaders to step forward. Will you be among them?
